MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Wednesday, June 22, 2016

12:00pm-1:30pm
Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size

I. Obeso, E. Casabona, R. Rodríguez-Rojas, N. Pavón, R. Macías, M.L. Bringas, J.A. Obeso, M. Jahanshahi (Madrid, Spain)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Utility of the Mayo sleep questionnaire in predicting final autopsy diagnosis of alpha-synucleinopathy

D. Shprecher, J. Hentz, C. Adler, B. Dugger, H. Shill, E. Driver-Dunkley, S. Mehta, M. Sabbagh, C. Belden, R. Savica, L. Sue, T. Beach (Sun City, AZ, USA)

Clinical Phenomenology and Rating Scales
12:00pm-1:30pm
Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital

S.C. Cerquera Cleves, S.J. Romero Vanegas, F. Cruz Sanabria, C. Ruiz de Sánchez, F.F. Pretelt Burgos (Bogotá, Colombia)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Validation of the Hebrew version of the International Parkinson and Movement Disorder Society—unified Parkinson’s disease rating scale (MDS-UPDRS)

J. Zitser, A. Bar David, H. Shabtai, A. Ezra, M. Brozgol, C. Peretz, A. Rozenberg, T. Herman, G.T. Setbbins, C.G. Goetz, B.C. Tilley, S.T. Luo, L. Wang, N. Giladi, T. Gurevich (Tel Aviv, Israel)

Rating scales  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Validation of the Seoul-instrumental activity of daily living in the detection of dementia in Parkinson’s disease

S.J. Kim, E.J. Chung (Busan, Korea)

Parkinson's disease: Cognition  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Validity and reliability of the Turkish version of the scales for outcomes in Parkinson’s disease-autonomic questionnaire (SCOPA-AUT)

H. Yasar, M.G. Senol, S. Tasdemir, U.H. Ulas, S. Alay (Ankara, Turkey)

Rating scales  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Verbal fluency deficits in essential tremor patients: Underlying structural changes

E.A. Pelzer, C. Nelles, D.J. Pedrosa, L. Burghaus, C. Eggers, C. Melzer, M. Tittgemeyer, L. Timmermann (Cologne, Germany)

Neuroimaging (non-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD trial

J.L. Purks, A. Zeymo, N.M. Shara, K.E. Anderson, I. Shoulson (Washington, DC, USA)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2
12:00pm-1:30pm
Vestibular evoked myogenic potentials as biomarkers for non-motor symptoms of Parkinson’s disease

A. Shalash, D. Hassan (Cairo, Egypt)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley